Literature DB >> 10942413

Coagulation and fibrinolytic activities in 2 siblings with beta(2)-glycoprotein I deficiency.

R Takeuchi1, T Atsumi, M Ieko, H Takeya, S Yasuda, K Ichikawa, A Tsutsumi, K Suzuki, T Koike.   

Abstract

beta(2)-Glycoprotein I (beta(2)GPI) is a major antigen for antiphospholipid antibodies, and its multiple in vitro functions have been reported. This glycoprotein not only down-regulates thrombin formation by inhibiting contact activation or prothrombinase activity, but also up-regulates coagulation by reducing protein C anticoagulant activity. However, the in vivo roles of beta(2)GPI remain obscure. Coagulation and fibrinolytic characteristics were investigated in individuals with beta(2)GPI deficiency. An apparently healthy woman and her brother are homozygotes for beta(2)GPI deficiency. In these patients, Russell viper venom time was shortened (40.4 seconds; normal range, 47.8 +/- 4.95 seconds), but all markers of thrombin generation and fibrin turnover were within normal ranges. Exogenous activated protein C adequately prolonged the clotting time of the beta(2)GPI-deficient plasma, and euglobulin lysis time was also normal. Thus, elevated thrombin generation, enhancement of activated protein C response, and an altered fibrinolytic system were not found in congenitally beta(2)GPI-deficient plasma. (Blood. 2000;96:1594-1595)

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10942413

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  5 in total

1.  β₂-Glycoprotein-1 autoantibodies from patients with antiphospholipid syndrome are sufficient to potentiate arterial thrombus formation in a mouse model.

Authors:  Ariela Arad; Valerie Proulle; Richard A Furie; Barbara C Furie; Bruce Furie
Journal:  Blood       Date:  2011-01-18       Impact factor: 22.113

2.  Complement Activation and Thrombin Generation by MBL Bound to β2-Glycoprotein I.

Authors:  Paolo Durigutto; Paolo Macor; Nicola Pozzi; Chiara Agostinis; Fleur Bossi; Pier Luigi Meroni; Claudia Grossi; Maria O Borghi; William Planer; Peter Garred; Francesco Tedesco
Journal:  J Immunol       Date:  2020-08-05       Impact factor: 5.422

3.  β₂-glycoprotein I inhibits VEGF-induced endothelial cell growth and migration via suppressing phosphorylation of VEGFR2, ERK1/2, and Akt.

Authors:  Wen-Chin Chiu; Jan-Yu Lin; Tzong-Shyuan Lee; Li-Ru You; An-Na Chiang
Journal:  Mol Cell Biochem       Date:  2012-09-06       Impact factor: 3.396

4.  A novel dimeric inhibitor targeting Beta2GPI in Beta2GPI/antibody complexes implicated in antiphospholipid syndrome.

Authors:  Alexey Kolyada; Chang-Jin Lee; Alfredo De Biasio; Natalia Beglova
Journal:  PLoS One       Date:  2010-12-15       Impact factor: 3.240

5.  β2-Glycoprotein I Inhibits Vascular Endothelial Growth Factor-Induced Angiogenesis by Suppressing the Phosphorylation of Extracellular Signal-Regulated Kinase 1/2, Akt, and Endothelial Nitric Oxide Synthase.

Authors:  Wen-Chin Chiu; Tzeon-Jye Chiou; Meng-Ju Chung; An-Na Chiang
Journal:  PLoS One       Date:  2016-08-31       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.